Skip to main content

Cordlife's Medical and Technical Team

Our Medical and Technical Team is committed to ensuring that Cordlife meets the best international standards in all that we do. From the review of our day-to-day operations, to being at the forefront of technological innovation and finally, whenever a cord blood unit is required for a transplant release, we have our team of experts to focus on delivering the best to our Cordlife parents.

Meet our Panel of Experts

Dr Chiew Yoke Fong
Medical Director
Cordlife Group Limited
  • Bachelor of Medicine, Bachelor of Surgery from the National University of Singapore
  • Masters in Internal Medicine from the National University of Singapore
  • Doctor of Medicine from the National University of Singapore
  • Masters in Medical Microbiology from London Hospital Medical College
  • Fellow, Royal College of Pathologists of Australasia
  • Specialist in Pathology with work experiences: in New Zealand - Dunedin Hospital; in Singapore - National University Hospital, Alexandra Hospital, Changi General Hospital
  • Former advisor of the World Health Organization

Dr Arvin C. Faundo
Medical Director
Cordlife Philippines
Cordlife Indonesia
  • Bachelor of Science in Medical Technology (summa cum laude) Cebu Doctors' College, Cebu City, Philippines
  • Doctor of Medicine from the University of the Philippines
  • Training in Hematopathology & Stem Cell Transplantation, Memorial Sloan-Kettering Cancer Center, New York
  •  Consultant in Stem Cell Transplantation: Asian Hospital since 2004, St. Luke's Global City since 2011

Dr. Cheryl Tiuseco
Assistant Medical Director
Cordlife Philippines
  • Bachelor of Science in Medical Technology (Cum Laude) at Far Eastern University - Dr. Nicanor Reyes Medical Foundation
  • Doctor of Medicine, Far Eastern University - Dr. Nicanor Reyes Medical Foundation
  • Residency Training in Obstetrics and Gynecology, Cardinal Santos Medical Center
  •  Fellowship Training in Infectious Diseases for OB-GYN, Philippine General Hospital
  •  Consultant OB-GYN in Cardinal Santos Medical Center, Dr. Jesus Delgado Memorial Hospital and Pasig City General Hospital
Professor Dr Menaka Hariharan
Medical Director
StemLife Berhad
  • Bachelor of Medicine, Bachelor of Surgery and Masters, Masters of Pathology (Haematology and Transfusion Medicine) from University of Malaya, Fellow of Royal College of Pathologists of Australasia and Fellow of Academy of Medicine of Malaysia.
  • Trained in cryopreservation of bone marrow and peripheral blood stem cells at Fred Hutchinson Cancer Centre (USA) with more than 30 years of experience in stem cell field and research.
  • Former Head and Professor of Department of Pathology, Faculty of Medicine, University of Malaya, Former Member of Pioneer Bone Marrow Transplant (BMT) Unit in University of Malaya, Adjunct Professor, John Aldwyn Gifted University, Seychelles and Visiting Consultant Haematopathologist at Assunta Hospital, Quantum Diagnostics Laboratory.

Dr. Soumyadeep Seal
Medical Director
Cordlife India
  • Bachelor of Medicine, Bachelor of Surgery from West Bengal University of Health Sciences, India.
  • Doctor of Medicine in Medical Microbiology from Utkal University, India.
  • Former Young Scientist Member of European Society of Clinical Microbiology & Infectious Diseases.
  • Former Consultant Clinical Microbiologist and Infection Control Preventionist at Apollo Hospital, Bhubaneswar, India and Woodlands Multispeciality Hospital, India.
  • Former Clinical Associate of Bone Marrow Transplant Unit at AMRI Kolkata, India, which is a premier private healthcare provider of Eastern India.
  • Conducted global academic trials from India on antimicrobial resistance; A.T.L.A.S & S.M.A.R.T (IHMA Chicago, Illinois).
  • Former member of the West Bengal State Government program against prevention of spread of Malaria and surveillance measures in 2012.
  • In-depth experience in laboratory administration, set-ups and management within both government and diagnostics settings.
  • Published over 10 peer-reviewed national & international scientific journals.

Dr. Kevin K.W. Chik
Medical Director
Cordlife Hong Kong & Healthbaby Hong Kong
  • MBCHB(CUHK)
  • MRCP(UK)
  • DCH(Ireland)
  • FHKAM(Paed)
  • FHKC(Paed)
  • Associate Professor in The Lady Pao Children’s Cancer Centre, Prince of Wales Hospital

Dr Zhu PengCheng
Laboratory and Technical Director
(Philippines and Malaysia)
  • Holds a Doctor of Philosophy in Cell and Molecular Biology from School of Biological Sciences, Nanyang Technological University, Singapore
  • Has over 10 years of research experience in cancer biology, wound healing biology and drug discovery
  • Former Senior Research Fellow of College of Science, Nanyang Technological University.
  • Has released numerous peer-reviewed scientific publications in academic journals (Cancer Cell, Blood, Journal of Controlled Release, etc.), with over 975 citations as of January 2019
  • Invited peer-reviewing member for international scientific journals (Oncogene, Cell Death & Diseases, etc.)

Dr Inez Wong
Senior Consultant Paediatric Ophthalmologist
MBBChir (Cambridge), MA
MMed, FRCSEd (Ophth),
FRCOphth (London), FAMS
Medical Advisor
Eyescreen (Singapore)
  • Specialise in Paediatric Ophthalmology & Strabismus, Cataract Surgery & Comprehensive Ophthalmology, LASIK & Refractive Surgery
  • Director of Paediatric Ophthalmology and Strabismus Service at Eagle Eye Centre
  • Adjunct senior research scientist at Singapore Eye Research Institute (SERI)
  • Visiting Consultant at National University Hospital (NUH)
  • Former Head of the Paediatric Ophthalmology and Strabismus Service at NUH
  • Former Assistant Professor and Undergraduate Medical Education Director in Ophthalmology at the National University of Singapore (NUS)
  • Former Visiting Consultant at Jurong Health Services (JHS) and Health Promotion Board (HPB)

Dr Shimi Mahesh Kumar
Medical Advisor Metascreen
  • MBBS. Terna Medical College, Maharashtra University of Health Science
  • M.D. LTMG hospital, Maharashtra University of Health Science
  • Former Clinical Biochemist Thyrocare Technologies, Corporate Head office
  • Consultant in all aspects of Screening and Diagnosis of Inborn Error of Metabolisms

Why do parents save their baby's cord blood and cord lining?

Rich source of stem cells

Your baby’s umbilical cord has the youngest and most active stem cells compared with other stem cell sources such as embryo, bone marrow, and peripheral blood.

Proven use in transplants

More than 80 diseases can potentially be treated with cord blood, and 60,000 transplants have taken place worldwide.

Untapped clinical potential

Researchers all over the world are learning how to use stem cells to treat more diseases and repair damaged tissue or organs.

Treatment options for the family

The stem cells you stored are a perfect match for your baby, and they could be used to treat other members of your family.

Readily available for a lifetime
Readily available for a lifetime

Stem cells can be kept indefinitely if they are properly stored, and you can retrieve them whenever you need them.

Getting Started

Enrol Now

The collection of cord blood is a simple procedure that poses no risk to you or your baby. It is important that you make your banking decision before your due date so that you and your caregivers can be ready for the collection. You only have one chance to collect your baby's cord blood at birth, so this is a critical decision. 

Price Plans

Contact us to know more about the latest price and information
Hong Kong: (852) 3980 2888
Macau: (853) 6881 0781
WhatsApp:  (852) 9660 1317

Download Free Information Kit

Download FREE information kit to know more about the benefits of cord blood banking and Cordlife.

The Most Trustworthy Among O&G Specialists

Cordlife has been voted* as the most trustworthy cord blood bank by the private O&G specialists in Hong Kong. As the number 1 choice of these specialist doctors, you can have the confidence in choosing us as your preferred cord blood bank in Hong Kong.

*In an independent study conducted in 2010 by one of Asia's largest market research companies, ACORN.